We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+8.33%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$518B
AUM Growth
+$24.3B
Cap. Flow
-$1.52B
Cap. Flow %
-0.29%
Top 10 Hldgs %
29.53%
Holding
15,731
New
1,614
Increased
6,434
Reduced
5,866
Closed
1,610

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$555M
2
C icon
Citigroup
C
+$407M
3
MDT icon
Medtronic
MDT
+$401M
4
CMG icon
Chipotle Mexican Grill
CMG
+$392M
5
GILD icon
Gilead Sciences
GILD
+$362M

Sector Composition

Rank Sector Weight
1 Technology 3.02%
2 Healthcare 2.92%
3 Consumer Discretionary 2.17%
4 Financials 2.1%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRCC icon
10601
PUT
BRC Inc
BRCC
$213M
$138K ﹤0.01%
40,400
+17,300
+75% +$79.3K
PSTX
10602
CALL
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$138K ﹤0.01%
48,300
-86,400
-64% -$267K
BCYC
10603
PUT
Bicycle Therapeutics
BCYC
$273M
$138K ﹤0.01%
6,100
+3,600
+144% +$83K
FNA
10604
CALL
DELISTED
Paragon 28, Inc.
FNA
$138K ﹤0.01%
20,600
+19,600
+1,960% +$148K
BLUE
10605
PUT
DELISTED
bluebird bio
BLUE
$138K ﹤0.01%
13,240
+1,740
+15% +$28.9K
ABUS icon
10606
PUT
Arbutus Biopharma
ABUS
$924M
$137K ﹤0.01%
35,700
+5,800
+19% +$22.2K
TSQ icon
10607
CALL
Townsquare Media
TSQ
$104M
$137K ﹤0.01%
13,500
-19,000
-58% -$204K
ESPO icon
10608
PUT
VanEck Video Gaming and eSports ETF
ESPO
$259M
$137K ﹤0.01%
+1,800
New +$125K
PL icon
10609
CALL
Planet Labs
PL
$8.8B
$137K ﹤0.01%
61,400
+56,300
+1,104% +$125K
DNLI icon
10610
PUT
Denali Therapeutics
DNLI
$3.9B
$137K ﹤0.01%
4,700
-3,600
-43% -$89.2K
USAU icon
10611
PUT
US Gold Corp
USAU
$245M
$137K ﹤0.01%
23,500
+5,700
+32% +$31.9K
BTSG icon
10612
CALL
BrightSpring Health Services
BTSG
$12.2B
$137K ﹤0.01%
9,300
+7,400
+389% +$92.7K
FTRI icon
10613
First Trust Exchange-Traded Fund II First Trust Indxx Global Natural Resources Income ETF
FTRI
$130M
$136K ﹤0.01%
10,117
-53,501
-84% -$707K
BZUN
10614
CALL
Baozun
BZUN
$165M
$136K ﹤0.01%
38,100
-32,300
-46% -$79.9K
CRVS icon
10615
PUT
Corvus Pharmaceuticals
CRVS
$1.25B
$136K ﹤0.01%
25,800
+10,400
+68% +$37.3K
WTTR icon
10616
PUT
Select Water Solutions
WTTR
$2.69B
$136K ﹤0.01%
+12,200
New +$134K
IOSP icon
10617
PUT
Innospec
IOSP
$2.31B
$136K ﹤0.01%
+1,200
New +$140K
VERA icon
10618
Vera Therapeutics
VERA
$2.28B
$136K ﹤0.01%
3,070
-1,581
-34% -$60K
CVV icon
10619
CVD Equipment Corp
CVV
$56.1M
$136K ﹤0.01%
40,962
+27,313
+200% +$101K
CASI
10620
DELISTED
CASI Pharmaceuticals
CASI
$135K ﹤0.01%
+22,714
New +$147K
CRDF icon
10621
Cardiff Oncology
CRDF
$74.9M
$135K ﹤0.01%
50,546
-5,250
-9% -$12.4K
IGIC icon
10622
PUT
International General Insurance
IGIC
$1.16B
$135K ﹤0.01%
7,100
-7,600
-52% -$128K
TARS icon
10623
PUT
Tarsus Pharmaceuticals
TARS
$3.04B
$135K ﹤0.01%
4,100
+2,400
+141% +$67.5K
NEWT icon
10624
CALL
NewtekOne
NEWT
$376M
$135K ﹤0.01%
10,800
+5,500
+104% +$69.8K
SCSC icon
10625
CALL
Scansource
SCSC
$1.08B
$134K ﹤0.01%
2,800
+2,100
+300% +$99.4K

Similar funds

Citadel Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Citadel Advisors's Q3 2024 filing shows 1,614 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
  • Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
  • Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
  • Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
  • Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
  • Citadel Advisors opened 1,614 new positions and closed 1,610 in Q3 2024.
  • Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.